Age-specific incidence of Alzheimer's disease in a community population - PubMed (original) (raw)
. 1995 May 3;273(17):1354-9.
Affiliations
- PMID: 7715060
Age-specific incidence of Alzheimer's disease in a community population
L E Hebert et al. JAMA. 1995.
Abstract
Objective: To determine age-specific incidence rates of clinically diagnosed Alzheimer's disease.
Design: Cohort, followed a mean of 4.3 years.
Setting: East Boston, Mass.
Participants: Of 2313 persons aged 65 years and older who were initially free of Alzheimer's disease, 1601 participated in the ascertainment of incident disease (80% of survivors), 409 declined participation, and 303 died before the end of the follow-up period. A stratified sample of 642 persons received detailed clinical evaluation.
Outcome measure: Diagnosis of new probable Alzheimer's disease through structured clinical evaluation including neurologic, neuropsychological, and psychiatric examination. Community incidence rates were computed by 5-year age groups, adjusted for gender, single year of age, length of follow-up interval, and sampling design.
Results: The estimated annual incidence of Alzheimer's disease in the population was 0.6% (95% confidence interval [CI], 0.3% to 0.9%) for persons aged 65 to 69 years, 1.0% (95% CI, 0.6% to 1.4%) for persons aged 70 to 74 years, 2.0% (95% CI, 1.3% to 2.7%) for persons aged 75 to 79 years, 3.3% (95% CI, 2.2% to 4.4%) for persons aged 80 to 84 years, and 8.4% (95% CI, 3.7% to 13.1%) for persons aged 85 years and older.
Conclusions: The incidence of Alzheimer's disease is substantial and is approximately 14 times higher among persons older than 85 years compared with those between 65 and 69 years of age.
Similar articles
- Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported.
Evans DA, Funkenstein HH, Albert MS, Scherr PA, Cook NR, Chown MJ, Hebert LE, Hennekens CH, Taylor JO. Evans DA, et al. JAMA. 1989 Nov 10;262(18):2551-6. JAMA. 1989. PMID: 2810583 - Risk of head and traumatic brain injuries associated with antidepressant use among community-dwelling persons with Alzheimer's disease: a nationwide matched cohort study.
Taipale H, Koponen M, Tanskanen A, Lavikainen P, Sund R, Tiihonen J, Hartikainen S, Tolppanen AM. Taipale H, et al. Alzheimers Res Ther. 2017 Aug 1;9(1):59. doi: 10.1186/s13195-017-0285-3. Alzheimers Res Ther. 2017. PMID: 28764750 Free PMC article. - Risk of death from Alzheimer's disease in a community population of older persons.
Evans DA, Smith LA, Scherr PA, Albert MS, Funkenstein HH, Hebert LE. Evans DA, et al. Am J Epidemiol. 1991 Aug 15;134(4):403-12. doi: 10.1093/oxfordjournals.aje.a116102. Am J Epidemiol. 1991. PMID: 1877601 - Sources of variability in prevalence rates of Alzheimer's disease.
Corrada M, Brookmeyer R, Kawas C. Corrada M, et al. Int J Epidemiol. 1995 Oct;24(5):1000-5. doi: 10.1093/ije/24.5.1000. Int J Epidemiol. 1995. PMID: 8557432 Review. - Is case-ascertainment of Alzheimer's disease in field surveys practicable?
Henderson AS, Jorm AF. Henderson AS, et al. Psychol Med. 1987 Aug;17(3):549-55. doi: 10.1017/s0033291700025800. Psychol Med. 1987. PMID: 3306749 Review. No abstract available.
Cited by
- The Role of Copper in Alzheimer's Disease Etiopathogenesis: An Updated Systematic Review.
Sabalic A, Mei V, Solinas G, Madeddu R. Sabalic A, et al. Toxics. 2024 Oct 17;12(10):755. doi: 10.3390/toxics12100755. Toxics. 2024. PMID: 39453175 Free PMC article. Review. - Exploring crystallized and fluid intelligence in down syndrome using graph theory.
Lifshitz H, Shnitzer-Meirovich S, Koslovsky M, Yozevitch R. Lifshitz H, et al. Sci Rep. 2024 Oct 10;14(1):23738. doi: 10.1038/s41598-024-74815-5. Sci Rep. 2024. PMID: 39390071 Free PMC article. - The importance of education for understanding variability of dementia onset in the United States.
Cha H, Farina MP, Chiu CT, Hayward MD. Cha H, et al. Demogr Res. 2024 Jan-Jun;50:733-762. doi: 10.4054/demres.2024.50.26. Epub 2024 Apr 9. Demogr Res. 2024. PMID: 38872908 Free PMC article. - Synthesis, In Vitro Biological Evaluation and Molecular Modeling of Benzimidazole-Based Pyrrole/Piperidine Hybrids Derivatives as Potential Anti-Alzheimer Agents.
Tariq S, Rahim F, Ullah H, Sarfraz M, Hussain R, Khan S, Khan MU, Rehman W, Hussain A, Bhat MA, Farooqi MK, Shah SAA, Iqbal N. Tariq S, et al. Pharmaceuticals (Basel). 2024 Mar 24;17(4):410. doi: 10.3390/ph17040410. Pharmaceuticals (Basel). 2024. PMID: 38675373 Free PMC article. - Toward the right treatment at the right time: Modeling the trajectory of cognitive decline to identify the earliest age of change in people with Alzheimer's disease.
Baksh RA, Strydom A, Carter B, Carriere I, Ritchie K. Baksh RA, et al. Alzheimers Dement (Amst). 2024 Mar 7;16(1):e12563. doi: 10.1002/dad2.12563. eCollection 2024 Jan-Mar. Alzheimers Dement (Amst). 2024. PMID: 38463041 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical